Comparison

Vafidemstat European Partner

Item no. HY-112623-50mg
Manufacturer MedChem Express
CASRN 1357362-02-7
Amount 50 mg
Quantity options 100 mg 10mM/1mL 10 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.53
Formula C19H20N4O2
Citations [1]ORYZON presents data on the Phase I trial with ORY-2001 at the 13th International Conference on Alzheimer’s and Parkinson’s diseases<br/>[2]ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2018.
Smiles NC1=NN=C(O1)CN[C@H]2[C@H](C3=CC=C(OCC4=CC=CC=C4)C=C3)C2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias ORY-2001
Similar products 1357362-02-7
Available
Product Description
Vafidemstat (ORY-2001) is an oral, brain penetrant, dual lysine-specific histone demethylase (LSD1)/MAO-B inhibitor[1].
StorageTemperature
-20°C, 3 years (Powder)
Shipping
Blue Ice
Manufacturers Applications
Neuroscience-Neurodegeneration
MolecularWeight
336.39
Clinical Information
Phase 2
Manufacturers Research Area
Neurological Disease
Solubility
DMSO : 50 mg/mL (ultrasonic)
Target
Histone Demethylase; Monoamine Oxidase
Manufacturers Target
Histone Demethylase; Monoamine Oxidase
Isoform
KDM1/LSD1
Manufacturers Pathway
Epigenetics; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close